Apar Kishor Ganti

Has grant

Professor

University of Nebraska Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Research Cancer Research professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Role of MUC5AC in promoting CNS metastasis in Non-Small Cell Lung Cancer

Open Date: 2020-04-01

Close Date: 2024-03-31

Grant: Close

Fred & Pamela Buffett Cancer Center Support Grant

Open Date: 1984-07-01

Close Date: 2021-07-31

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (7)

Karim El‐Kersh

UNITED STATES

View details

Maneesh Jain

UNITED STATES

View details

Nathanael Fillmore

Assistant Professor of Medicine

Harvard Medical School

UNITED STATES

View details

Surinder K. Batra

University of Nebraska Medical Center

UNITED STATES

View details

Hossein Borghaei

Professor and Chief, Thoracic Oncology

Fox Chase Cancer Center

UNITED STATES

View details

Ruxana Sadikot

Professor of Medicine

University of Nebraska Omaha

UNITED STATES

View details

Parthasarathy Seshacharyulu

Assistant professor

University of Nebraska Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Apar Kishor Ganti

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

A retrospective analysis of immune checkpoint inhibitors in patients with preexisting organ dysfunction

GPCRs and fibroblast heterogeneity in fibroblast‐associated diseases

Clinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes

Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study

Targeting the EGFR signaling pathway in cancer therapy: What’s new in 2023?

Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients

Mucins as Potential Biomarkers for Early Detection of Cancer

Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru

Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease

Novel targeted therapies for advanced non-small lung cancer

Collaborators (7)

Karim El‐Kersh

Maneesh Jain

Nathanael Fillmore

Surinder K. Batra

Hossein Borghaei

Ruxana Sadikot

Parthasarathy Seshacharyulu

Make your next move.